Universal-Beteiligungs- und Servicegesellschaft
FOLD

Universal-Beteiligungs- und Servicegesellschaft’s Amicus Therapeutics FOLD Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56M Sell
176,804
-54,533
-24% -$782K ﹤0.01% 1158
2025
Q4 		$3.29M Sell
231,337
-92,164
-28% -$905K 0.01% 1076
2025
Q3 		$2.55M Buy
323,501
+15,191
+5% +$108K ﹤0.01% 1175
2025
Q2 		$1.77M Buy
308,310
+95,565
+45% +$617K ﹤0.01% 1292
2025
Q1 		$1.74M Buy
+212,745
New +$1.97M ﹤0.01% 1266

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's FOLD Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Amicus Therapeutics (FOLD) stake by 24% in Q1 2026, selling an estimated $782K and leaving 176,804 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in FOLD in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.29M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 176,804 shares of Amicus Therapeutics worth $2.56M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 54,533 Amicus Therapeutics shares in Q1 2026, an estimated $782K.
  • Amicus Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #1158 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Amicus Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Amicus Therapeutics position peaked at $3.29M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.